Reported Reactions

Devices › Mesh, surgical, synthetic, urogynecologic, for stress urinary incontinence, retropubic or transobturator

Device brand name · Align urethral support system retropubic

Align Urethral Support System Retropubic: medical device reports filed with FDA

169 reports name it, 2012–2024. Manufacturer given most often on reports: C R Bard Covington -1018233. Product code OTN.

169
device reports naming the brand
0% of all MAUDE reports · about 12 a year
0
reports, 12 months to August 2026
1 in the 12 months before
0%
classified as malfunction
1.6% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

169 medical device reports received by FDA name the brand "Align Urethral Support System Retropubic" (align urethral support system retropubic); the manufacturer given most often on reports is C R Bard Covington -1018233; received from January 2012 to October 2024. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

0 reports arrived in the 12 months to August 2026, against 1 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all mesh, surgical, synthetic, urogynecologic, for stress urinary incontinence, retropubic or transobturator reports (product code OTN) death is recorded in 1% and malfunction in 1.6%. Event type is the reporter's classification of the report, not a verified outcome.

Reports by month, five years

036Sep 2021: 0Oct 2021: 3Nov 2021: 1Dec 2021: 62022Jan 2022: 0Feb 2022: 0Mar 2022: 0Apr 2022: 0May 2022: 1Jun 2022: 0Jul 2022: 1Aug 2022: 1Sep 2022: 0Oct 2022: 0Nov 2022: 0Dec 2022: 02023Jan 2023: 1Feb 2023: 0Mar 2023: 0Apr 2023: 0May 2023: 0Jun 2023: 1Jul 2023: 1Aug 2023: 0Sep 2023: 0Oct 2023: 0Nov 2023: 0Dec 2023: 12024Jan 2024: 0Feb 2024: 0Mar 2024: 0Apr 2024: 0May 2024: 0Jun 2024: 0Jul 2024: 0Aug 2024: 2Sep 2024: 0Oct 2024: 1Nov 2024: 0Dec 2024: 02025Jan 2025: 0Feb 2025: 0Mar 2025: 0Apr 2025: 0May 2025: 0Jun 2025: 0Jul 2025: 0Aug 2025: 0Sep 2025: 0Oct 2025: 0Nov 2025: 0Dec 2025: 02026Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

042842012: 620122013: 3720132016: 320162017: 320172019: 8420192020: 1320202021: 1320212022: 320222023: 420232024: 32024

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%169
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%169
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 38,649 reports carrying product code OTN. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Therapeutic or diagnostic output failure10.6%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Injurya physical injury12976.3%
Painpain, site not specified5029.6%
Incontinence3017.8%
Disability2112.4%
Erosion2011.8%
Micturition urgency2011.8%
Urinary tract infectionbladder or urinary infection2011.8%
Abdominal painstomach or belly pain1710.1%
Urinary frequency / polyuria137.7%
Urinary retentionbeing unable to empty the bladder137.7%
Blood loss116.5%
Prolapse116.5%
Intermenstrual bleeding84.7%
Urinary incontinenceleaking urine84.7%
Discomfortdiscomfort74.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureAlign Urethral Support System RetropubicProduct code OTNAll MAUDE reports
Reports16938,64926,136,888
Share of that pool—0.4%0%
Classified as death, per 1,000 reports0109
Classified as injury100%97.4%36.2%
Classified as malfunction0%1.6%62.3%
Filed by the manufacturer100%97.8%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code OTN

BrandReportsLatest 12 monthsClassified as death
Gynecare Tvt Retropubic System5,75200%
Gynecare Tvt Obturator System4,33000%
Tension Free Vaginal Tape9,35500.1%
Gynecare Mesh Unknown5,83030.1%
Gynecare Tvt Oburator System1,57800.1%
Tension Free Vaginal Tape Unknown Product1,161240%
Gynecare Tvt-Aa Abdominal90500%
Advantage Fit System1,496100.1%
Gynecare Tvt Obturator868150%
Uretex Support Pp Kit X199900.1%
Gynecare Tvt Exact Continence System68200%
Tension Free Vaginal Tape - Obturator Unknown Prod67650%
Advantage? System3,537130%
Obtryx System6,03110%
Gynecare TVT67930%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Align Urethral Support System Retropubic reports

How many FDA reports name Align Urethral Support System Retropubic?

169 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

therapeutic or diagnostic output failure (0.6%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Align Urethral Support System Retropubic was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.